This article is more than 5 years old. Information may no longer be current.
Cancer center announces clinical partnership in Latin America
Click Here to Manage Email Alerts
The University of Texas MD Anderson Cancer Center has announced a partnership with Hospital Israelita Albert Einstein in Brazil to develop multidisciplinary patient care model.
“Our mission and vision challenge us to be the single most impactful institution in relieving the burden of cancer globally, and we can achieve this by extending our brand of prevention, care, research and education to like-minded organizations worldwide,” Ronald DePinho, MD, president of MD Anderson, said in a press release. “Hospital Israelita Albert Einstein is recognized for its exceptional physicians, state-of-the-art facilities and high quality care, and we’re combining their excellence with MD Anderson’s vast cancer expertise.”
Hospital Israelita Albert Einstein (HIAE), a 489-bed private hospital in São Paulo, will be the first clinical extension of MD Anderson in Latin America and the first international member of MD Anderson Cancer Network, a handpicked group of hospitals and health systems with access to best practices, education, research and treatment protocols developed by MD Anderson.
“Brazil has a cancer burden of over a half million cases a year. By expanding our collaboration with Latin America’s leading hospital, we intend to address that challenge by delivering advanced and research-driven multidisciplinary care,” Amy Hay, vice president of business development at MD Anderson, said in the release. “Together, we’re changing cancer care delivery in Brazil for the benefit of patients across the region.”
As a member of the network, the hospital is intended to be operationally and clinically integrated with MD Anderson across the entire cancer care continuum and reflect MD Anderson’s multidisciplinary, research-driven and patient-centered care. For the first time in Latin America, patients will have access to a multidisciplinary, multispecialty cancer center with outpatient care, advanced treatment technologies and a full range of support services, within a single location.
“This marks a new era in cancer care delivery in Brazil,” Deborah Kuban, MD, professor in Radiation Oncology and MD Anderson’s clinical lead in the partnership said in the release. “This is a novel approach to cancer management in Latin America. Patients will have more than just one doctor dictating care. They’ll benefit from the attention of a full multidisciplinary team at Albert Einstein Hospital in Sao Paulo with the support and experience of MD Anderson in Houston.”
MD Anderson will provide HIAE with clinical care oversight, order sets and treatment algorithms. The clinical integration will also include planning and clinical program support, faculty and staff education and training, quality measurement and reporting tools, access to clinical trials and research collaborations. HIAE physicians will consult with MD Anderson faculty through tumor boards and visits while providing care based on the protocols and practice standards delivered at MD Anderson.